Stacey Hayward
Nurse Practitioner · Palmer, AKNPI 1942236054
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.7% of the total across 129 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 20 manufacturers reported payments, led by AbbVie at 29.9% of the total. Reporting peaked in 2022 at $780 and has fallen 80.0% since, to $156 in 2025. Among nurse practitioner clinicians in AK with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 129 payments — averaging $19.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$765
- Gilead$612
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$431
- AstraZeneca$144
- Intercept Pharmaceuticals, Inc.$135
- Johnson & Johnson$83
- plus $389 from 14 others
Across 8 payments — averaging $212.79 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Corcept Therapeutics$2K
What the payments were for
- Food & beverage$2,50098%
- Education$592%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 26 | $765 |
| Gilead | 45 | $612 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 26 | $431 |
| AstraZeneca | 4 | $144 |
| Intercept Pharmaceuticals, Inc. | 7 | $135 |
| Johnson & Johnson | 2 | $83 |
| Novo Nordisk | 1 | $79 |
| Eisai Inc. | 2 | $44 |
| Merck | 3 | $40 |
| Pfizer | 1 | $32 |
| Travere Therapeutics, Inc. | 3 | $22 |
| Orphalan Inc | 1 | $22 |
| Alnylam Pharmaceuticals Inc. | 1 | $22 |
| Lilly USA, LLC | 1 | $21 |
| Aimmune Therapeutics, Inc. | 1 | $20 |
| Siemens Medical Solutions USA, Inc. | 1 | $19 |
| Exact Sciences | 1 | $18 |
| Daiichi Sankyo Inc. | 1 | $17 |
| Pharmacosmos Therapeutics Inc. | 1 | $17 |
| Dova Pharmaceuticals | 1 | $16 |
How this compares
$2,559 in reported general payments places this provider in the 95th percentile of 212 nurse practitioner providers in Alaska.
Other nurse practitioner in Palmer
- Jessica BrayPalmer$5K
- Amanda EnosPalmer$5K
- Suesue ScottPalmer$655
- Tamara SimpsonWasilla$18K
- Charlotte NelsonWasilla$6K
- Ellen LentzWasilla$5K
- Wezzie MunthaliAnchorage$4K
- Lily GeorgeAnchorage$4K
- Samantha HamiltonWasilla$4K
- Genevieve CorbettAnchorage$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.